PVMCV
Polaris Venture Management Co V Portfolio holdings
AUM
$14.1M
This Quarter Return
+8.37%
1 Year Return
+121.41%
3 Year Return
+278.88%
5 Year Return
+1,121.38%
10 Year Return
–
AUM
$110M
AUM Growth
+$110M
(-20%)
Cap. Flow
-$12.6M
Cap. Flow
% of AUM
-11.38%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
11
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Cardlytics
CDLX
|
$12.6M |
Sector Composition
| 1 | Healthcare | 38.82% |
| 2 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Fate Therapeutics
FATE
$120M
| $25.3M | 22.91% |
1,139,783
| – | – |
|
2
Cartesian Therapeutics
RNAC
$261M
| $6.68M | 6.05% |
2,773,479
| – | – |
|
3
KALA BIO
KALA
$78.8M
| $4.97M | 4.5% |
565,289
| – | – |
|
4
X4 Pharmaceuticals
XFOR
$84.2M
| $3.12M | 2.82% |
311,492
| – | – |
|
5
Neuronetics
STIM
$220M
| $1.39M | 1.25% |
732,583
| – | – |
|
|
GNCA
6
DELISTED
Genocea Biosciences, Inc.
GNCA
| $423K | 0.38% |
246,078
| – | – |
|
|
ATYR
7
aTyr Pharma
ATYR
$527M
| $366K | 0.33% |
130,571
| – | – |
|
8
Pulmatrix
PULM
$18M
| $363K | 0.33% |
359,439
| – | – |
|
9
Dare Bioscience
DARE
$27.2M
| $277K | 0.25% |
326,243
| – | – |
|
|
10
Cardlytics
CDLX
$54.3M
| – | – |
-200,000
| Closed | -$12.6M |
|